Article
Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53.
Marine drugs - 20 Nov 2020
Ahn Yong Tae, Kim Min Sung, Kim Youn Sook, An Won Gun
Abstract excerpt
Astaxanthin (AST) is a product made from marine organisms that has been used as an anti-cancer supplement. It reduces pontin expression and induces apoptosis in SKBR3, a breast cancer cell line. Using Western blotting and qRT-PCR analyses, this study revealed that in the T47D and BT20 breast cancer cell lines, AST inhibits expression of pontin and mutp53, as well as the Oct4 and Nanog cancer stem cell (CSC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
